Since SIL reduced expression of activation markers on CD4+ T cells (Figure 5), the immunomodulatory effects of SIL may be clinically relevant for reducing HIV-induced immune activation. This evidence concerns the gene CD4 and squamous cell intraepithelial neoplasia.